DeepKinase
DeepKinase (嘉华药锐) is an AI-driven functional proteomics platform company focused on precision medicine and drug discovery. Leveraging its proprietary PCT patented DoTK® (Deep Omics of Tyrosine Kinase) platform, DeepKinase enables industrial-grade functional proteomic detection, providing a new dimension of life information to understand signaling pathway activity and immune function. The company's vision is to make cancer manageable by identifying the most effective drugs for individual patients. DeepKinase integrates mass spectrometry data with AI language models to enhance the accuracy and efficiency of proteomic analysis, supporting various stages of drug development including target discovery, mechanism of action studies, drug repositioning, and biomarker discovery. They have established partnerships with leading hospitals and enterprises across North America and China.
DeepKinase
DeepKinase (嘉华药锐) is an AI-driven functional proteomics platform company focused on precision medicine and drug discovery. Leveraging its proprietary PCT patented DoTK® (Deep Omics of Tyrosine Kinase) platform, DeepKinase enables industrial-grade functional proteomic detection, providing a new dimension of life information to understand signaling pathway activity and immune function. The company's vision is to make cancer manageable by identifying the most effective drugs for individual patients. DeepKinase integrates mass spectrometry data with AI language models to enhance the accuracy and efficiency of proteomic analysis, supporting various stages of drug development including target discovery, mechanism of action studies, drug repositioning, and biomarker discovery. They have established partnerships with leading hospitals and enterprises across North America and China.